Wei Dai

Dr. Wei Dai


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 July 2018 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
YNYoukang Ni
Youkang Ni
PLPing Lu
Ping Lu
ZYZhi Yang
Zhi Yang
WWWenlong Wang
Wenlong Wang
WDWei Dai
Wei Dai
FLFayu Liu
Fayu Liu
The repair and reconstruction of maxillary and mandibular extensive defects have put huge challenges to surgeons. The fibular free flap (FFF) is one of the standard treatment choices for reconstruction. The conventional FFF has deficiencies, such as forming poor oral mucosa, limited flap tissue, and perforator vessel variation. To improve the use of FFF, we add the flexor hallucis longus (FHL) in the flap (FHL-FFF). In this paper, we described the advantage and indication of FHL-FFF and conducted a retrospective study to compare FHL-FFF and FFF without FHL. Fifty-four patients who underwent FFF were enrolled and divided into two groups: nFHL group (using FFF without FHL, 38 patients) and FHL group (using FHL-FFF, 16 patients). The perioperative clinical data of patients was collected and analyzed. The flaps all survived in two groups. We mainly used FHL to fill dead space, and the donor-site morbidity was slight. In FHL group, flap harvesting time was shorter (118.63 ± 11.76 vs 125.74 ± 11.33 min, P = 0.042), the size of flap’s skin paddle was smaller (16.5 (0–96) vs 21.0(10–104) cm2, P = 0.027) than nFHL group. There were no significant differences (P > 0.05) in hospital days, hospitalization expense, rate of perioperative complications, etc. between the two groups. Compared with FFF without FHL, FHL-FFF will neither affect the use of flap nor bring more problems. The FHL-FFF simplifies the flap harvesting operation. The FHL can form good mucosa and make FFF rely less on skin paddle. It can be used for adding flap tissue and dealing with perforator vessel variation in reconstruction of maxillary and mandibular extensive defects.

1 May 2025 in Genes & Diseases
Verified
Journal Article
Open access
QWQian Wang
Qian Wang
HZHongyan Zhang
Hongyan Zhang
SXShuzhen Xiang
Shuzhen Xiang
LZLan Zhang
Lan Zhang
JFJiajia Fan
Jiajia Fan
WDWei Dai
Wei Dai

10 November 2025 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
JFJiaJia Fan
JiaJia Fan
HZHongyan Zhang
Hongyan Zhang
LLLin Liu
Lin Liu
CWChunyu Wang
Chunyu Wang
SJShiheng Jia
Shiheng Jia
WDWei Dai
Wei Dai
Oral squamous cell carcinoma (OSCC) is an aggressive cancer with limited improvement in patient outcomes despite advances in surgery, chemotherapy, and radiotherapy. The LIM-only protein LMO4 functions as a transcriptional co-regulator and is known to be increased in several epithelial cancers, but its contribution to OSCC has not been well defined. In this study, we found that LMO4 expression was markedly higher in OSCC tissues and was associated with poorer overall survival. Cellular experiments showed that LMO4 enhanced OSCC cell proliferation, migration, and resistance to ferroptosis by promoting the ubiquitin–proteasome–dependent degradation of the tumor suppressor RAB17. Restoration of RAB17 expression reduced these malignant behaviors. In a nude mouse xenograft model, tumors with high LMO4 grew faster and displayed lower RAB17 protein levels. Taken together, our results indicate that LMO4 contributes to OSCC progression through post-translational regulation of RAB17 and ferroptosis control, suggesting that this pathway could serve as a new therapeutic target.

1 September 2025 in Genes & Diseases
Verified
Journal Article
Open access
SXShuzhen Xiang
Shuzhen Xiang
HZHongyan Zhang
Hongyan Zhang
QWQian Wang
Qian Wang
JFJiajia Fan
Jiajia Fan
SJShiheng Jia
Shiheng Jia
WDWei Dai
Wei Dai